Vyzulta and Acetaminophen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vyzulta (latanoprostene bunod) and Acetaminophen (acetaminophen). Common drug interactions include blister infected among females and plasma cell myeloma among males.

The phase IV clinical study analyzes what interactions people have when they take Vyzulta and Acetaminophen. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Vyzulta?

Vyzulta has active ingredients of latanoprostene bunod. It is often used in glaucoma. eHealthMe is studying from 740 Vyzulta users. Check the latest studies of Vyzulta.

What is Acetaminophen?

Acetaminophen has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 183,078 Acetaminophen users. Check the latest studies of Acetaminophen.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

13 people who take Vyzulta and Acetaminophen together, and have interactions are studied.

Vyzulta and Acetaminophen drug interactions.

What are the common drug interactions of Vyzulta and Acetaminophen, by gender? *:

female:

Blister infected (infection of small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood immunoglobulin g increased
Cellulitis (infection under the skin)
Cough
Eye infection
Eye inflammation
Fear
Immunisation reaction
Infusion related reaction
Infusion site bruising

male:

Plasma cell myeloma (cancer that begins in plasma cells)
Rash erythematous (redness of the skin)
Prostate cancer
Death
Somnolence (a state of near-sleep, a strong desire for sleep)

What are the common drug interactions of Vyzulta and Acetaminophen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood urine present
Rash
Arthralgia (joint pain)
Blood immunoglobulin g increased
Eye inflammation
Joint stiffness
Nasal inflammation (inflammation of nose)
Nephrolithiasis (calculi in the kidneys)
Visual field defect
Vitreous floaters (spots before the eyes)

60+:

Plasma cell myeloma (cancer that begins in plasma cells)
Rash erythematous (redness of the skin)
Infusion related reaction
Infusion site bruising
Infusion site erythema (reddening of the skin at infusion site)
Infusion site pruritus (severe itching at infusion site)
Laryngitis (inflammation of the larynx)
Localised infection (infection at the single location)
Malaise (a feeling of general discomfort or uneasiness)
Multiple allergies (allergy to multiple agents)

What are the existing conditions these people have? *

Mikulicz's Syndrome (abnormal enlargement of glands in the head and neck): 4 people, 30.77%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 23.08%
Blood Iron Abnormal: 3 people, 23.08%
Gout (uric acid crystals building up in the body): 3 people, 23.08%
Haemoglobin Decreased: 3 people, 23.08%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 3 people, 23.08%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 23.08%
Immunodeficiency Common Variable: 3 people, 23.08%
Joint Pain: 3 people, 23.08%
Migraine (headache): 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Vyzulta and Acetaminophen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously